Underuse of SARS-CoV-2–Neutralizing Monoclonal Antibodies in Skilled Nursing Facilities

Little is known about deployment of SARS-CoV-2–neutralizing monoclonal antibodies (mab) in skilled nursing facilities (SNFs), a high-risk population for COVID-19–related complications. We assessed the utilization of mabs in SNFs and identified facility characteristics associated with effective use.